CellVax Therapeutics, Inc. — Form D
CellVax Therapeutics, Inc. of MIAMI, FL, a company, filed a Form D exempt-offering notice with the SEC on 2024-10-04. The offering totals $5.0M, of which $2.1M was reported sold. Industry: Other.
Offering
- Filed: 2024-10-04
- Form: D
- Accession: 0002040125-24-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $2.1M
- Remaining: $2.9M
- Investors: 1
- Date of first sale: 2024-09-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-525918
Issuer
- Name: CellVax Therapeutics, Inc.
- CIK: 0002040125
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1951 NW 7TH AVENUE 3RD FLOOR, SUITE 130, MIAMI, FL, 33136
- Phone: 2159415916
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Fernando Kreutz | Director | Miami, FL |
| Alberto da Costa Stein | Director | Miami, FL |
| Fernando Kreutz | Executive Officer | Miami, FL |
More